G6PD表达敲减对人宫颈癌细胞miRNAs表达谱的影响

胡滔; 刘光彩; 洪颖; 陈红兰; 常业飞; 姜水; 檀雅欣; 习杨彦彬; 陈波

G6PD表达敲减对人宫颈癌细胞miRNAs表达谱的影响

1. 云南省第三人民医院医学检验科
2. 昆明医科大学基础医学院
3. 昆明医科大学科研实验中心

基金项目:

基金：国家自然科学基金资助项目 (81502377); 云南省应用基础研究计划资助项目 (2016FB139); 云南省教育厅科学研究基金资助项目 (2016ZDX044);

计量
- 文章访问数: 2854
- HTML全文浏览量: 1068
- PDF下载量: 48
- 被引次数: 0
出版历程
- 收稿日期: 2018-07-14

Effect of G6PD Knockdown on the Expression of miRNAs in Cervical Cancer Cells

Funds:

基金：国家自然科学基金资助项目 (81502377); 云南省应用基础研究计划资助项目 (2016FB139); 云南省教育厅科学研究基金资助项目 (2016ZDX044);

摘要

摘要: 目的比较G6PD表达敲减后人宫颈癌细胞HPV-C33A与HPV16+Siha以及HPV18+Hela中mi RNAs的表达差异, 进一步了解G6PD致瘤的分子机制。方法构建G6PD表达敲减的人宫颈癌细胞株, 运用mi RNAs芯片对各细胞株中mi RNAs进行对比分析, q RT-PCR对结果进行验证。结果 (1) 成功获得G6PD表达敲减的人宫颈癌细胞株C33A、Siha和Hela; (2) 与HPV-C33A相比, G6PD表达干扰后高危型HPV16+/18+人宫颈癌细胞株中出现多种mi RNAs差异表达的情况 (P<0.05) 。结论 G6PD在高危型HPV+人宫颈癌中的致瘤性与多种mi RNAs的差异表达相关。
- 宫颈癌 /
- 高危型人乳头瘤病毒16/18型 /
- G6PD /
- miRNAs
Abstract: Objective To explore the expression changes of miRNAs in HRHPV (16 and 18) infected (+) cervical cancer cells after G6 PD expression knock-down. Methods The G6 PD expression in HPV-C33 A, HPV16+Siha and HPV18+Hela cells was inhibited by RNA interference target G6 PD. Human micro RNA Microarray Kit and q RT-PCR were employed to determine the expression changes of mi RNA between different cell lines.Results The expression of G6 PD significantly decreased after RNA interference in different cervical cancer cell lines.Mi RNA microarrayand q RT-PCR analysis revealed that numerousmiRNAs in HPV+ Hela/Siha cells were expressional different from the control HPV-C33 A cells, following G6 PD knockdown. Conclusion The expression changes of various miRNAs following G6 PDknockdown are associated with the oncogenesis events of G6 PD in HR HPV infected cervical cancer cells.
- Cervical cancer /
- High-risk human papillomavirus (HR HPV) 16/18 infection /
- G6PD /
- miRNAs

HTML全文

参考文献(24)

[1]	[1] JEMAL A, BRAY F, CENTER M M, et al. Global cancer statistics[J]. CA Cancer J Clin, 2011, 61 (2) :69-90.
[2]	[2]ZUR HAUSEN H. Papillomaviruses and cancer:from basic studies to clinical application[J]. Nat Rev Cancer, 2002, 2 (5) :342-350.
[3]	[3]WALBOOMERS J M, JACOBS M V, MANOS M M, et al.Human papillomavirus is a necessary cause of invasive cervical cancer worldwide[J].J Pathol, 1999, 189 (1) :12-19.
[4]	[4]HU T, LI Y S, CHEN B, et al.Elevated glucose-6-phosphate dehydrogenase expression in the cervical cancer cases is associated with the cancerigenic event of high-risk human papillomaviruses[J]. Exp Biol Med (Maywood) , 2015, 240 (10) :1287-1297.
[5]	[5]HU T, ZHANG C, TANG Q, et al. Variant G6PD levels promote tumor cell proliferation or apoptosis via the STAT3/5 pathway in the human melanoma xenograft mouse model[J]. BMC Cancer, 2013, 13:251.
[6]	[6]ZHANG M, DONG B B, LU M, et al. mi R-429 functions as a tumor suppressor by targeting FSCN1 in gastric cancer cells[J]. Onco Targets Ther, 2016, 9:1123-1133.
[7]李瑞岩, 蒋传路.脑胶质瘤中G6PD蛋白的表达及与肿瘤分级的相关性[J].黑龙江医学, 2008, 32 (8) :573-575.
[8]	[8]KEKEC Y, PAYDAS S, TULI A, et al. Antioxidant enzyme levels in cases with gastrointesinal cancer[J]. Eur J Intern Med, 2009, 20 (4) :403-406.
[9]	[9]LANGBEIN S, FREDERIKS W M, ZUR HAUSEN A, et al.Metastasis is promoted by a bioenergetic switch:New targets for progressive renal cell cancer[J]. Cancer, 2008, 12 (2) :2422-2428.
[10]	[10]GERACI G, D'ELIA I, GAUDIO R. Evidence of genetic instability in tumors and normal nearby tissues[J]. PLo S ONE, 2010, 5 (2) :e9343.
[11]	[11]KOUDSTAAL J, MAKKINK B, OVERDIEP S H. Enzyme histochemical pattern in human tumours. II. Oxidoreductases in carcinoma of the colon and the breast[J]. Eur J Cancer, 1975, 11 (2) :111-115.
[12]	[12]BAHA M, YAMAOTO R, IISHI H, et al. Role of glucose-6-phosphate dehydrogenase on enhanced proliferation of pre-neoplastic and neoplastic cells in rat liver induced by N-nitrosomorpholine[J]. Int J Cancer, 1989, 43 (5) :892-895.
[13]	[13]HU T, CHANG YF, XIAO Z, et al. mi R-1 inhibits progression of high-risk papillomavirus-associated human cervical cancer by targeting G6PD[J].Oncotarget, 2016, 7 (52) :86103-86116.
[14]	[14]JOHN B, EERIGHT AJ, ARAVIN A, et al. Human MicroRNA targets[J]. PLo S Biol, 2004, 2 (11) :e363.
[15]	[15]SATOH J. Molecular network analysis of human micro RNA targetome:from cancers to Alzheimer’s disease[J]. Bio Data Min, 2012, 5 (1) :17.
[16]	[16]FUJII R, OSAKA E, SATO K, TOKUHASHI Y, et al.Mi R-1 Suppresses Proliferation of Osteosarcoma Cells by Up-regulating p21 via PAX3[J].Cancer Genomics Proteomics, 2019, 16 (1) :71-79.
[17]	[17]DU YY, ZHAO LM, CHEN L, et al. The tumor-suppressive function of mi R-1 by targeting LASP1 and TAGLN2 in esophageal squamous cell carcinoma[J]. J GastroenterolHepatol, 2015, 31 (2) :384-393.
[18]	[18]XU X, WU X, JIANG Q, et al. Downregulation of micro RNA-1 and micro RNA-145 contributes synergistically to the development of colon cancer[J]. Int J Mol Med, 2015, 36 (6) :1630-1638.
[19]	[19]KORI M, YALCIN ARGA K.Potential biomarkers and therapeutic targets in cervical cancer:Insights from the meta-analysis of transcriptomics data within network biomedicine perspective[J].PLo S One, 2018, 13 (7) :e0200717.
[20]	[20]LIANG H, LI Y, LUO RY, et al. MicroRNA-215 is a potential prognostic marker for cervical cancer[J]. J Huazhong Univ Sc i Technolog Med Sci, 2014, 34 (2) :207-212.
[21]	[21] LIANG H, LI Y, LUO RY, et al.MicroRNA-215 is a potential prognostic marker for cervical cancer[J].J Huazhong Univ Sci Technolog Med Sci, 2014, 34 (2) :207-212.
[22]	[22]SONG R, CONG L, NI G, et al.MicroRNA-195 inhibits the behavior of cervical cancer tumors by directly targeting HDGF[J].Oncol Lett, 2017, 14 (1) :767-775.
[23]	[23]WANG R, ZHAO N, LI S, et al. MicroRNA-195 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting the expression of VEGF, VAV2, and CDC42[J]. Hepatology, 2013, 58 (2) :642-653.
[24]	[24]ZHOU Q, HAN LR, ZHOU YX, et al.MiR-195 Suppresses Cervical Cancer Migration and Invasion Through Targeting Smad3[J].Int J Gynecol Cancer, 2016, 26 (5) :817-824.

相关文章(20)

[1]	崔湘杰, 陶玉芬, 朱兰芳, 姚宇峰, 史荔. HPV16 E6、E7多表位DNA疫苗的构建及免疫效果评估, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20240503
[2]	郭妮, 张承, 洪超, 刘伟鹏, 姚宇峰, 严志凌. KRAS基因3′UTR多态性与云南汉族人群宫颈癌及宫颈上皮内瘤变的相关性, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20240203
[3]	苗春霞, 王一娜, 张云霞. 宫颈癌组织中EMC6、C-myc及BCL-2的表达和预后, 昆明医科大学学报.
[4]	肖金宝, 赵骏达, 马俊旗. 下调HPV16 E6/E7表达宫颈癌细胞Siha上清液代谢组学, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20240104
[5]	刘倩, 哈提拉·吐尔逊, 阿仙姑·哈斯木. HLA-G通过促进活化性受体的表达增强NK细胞对宫颈癌细胞的杀伤作用, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20220714
[6]	陈红兰, 吴怡, 胡滔, 王玉明. 外周血G6PD活性检测对于感染高危型人乳头瘤病毒宫颈癌患者的诊断预后价值, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20220203
[7]	张娟, 张红芸. 宫颈管搔刮术在宫颈癌筛查中的价值, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20210822
[8]	陈紫红, 刘红, 刘明伟, 舒密, 南琼. MiRNA-145在消化系统恶性肿瘤中的研究进展, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20210334
[9]	谭丁及, 尹洪莉, 朱锐, 张曦, 余鑫, 飞勇, 李昕, 段铭, 何亮, 杨宏英. 宫颈上皮内瘤变和宫颈癌患者的阴道微生态特点, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20210821
[10]	卿清, 刘洋, 周红林. 宫颈癌筛查策略的研究进展, 昆明医科大学学报.
[11]	周栩茹, 王熙, 田洁, 谢玲玲, 许宏宇, 李晓兰. 黏附斑激酶在宫颈癌组织中表达及意义, 昆明医科大学学报.
[12]	胡滔, 洪颖, 陈红兰, 常业飞, 姜水, 习杨彦彬, 檀雅欣, 李珊, 刘光彩, 吴晓虹. miR-1对HR HPV 16~+/18~+宫颈癌细胞周期相关蛋白的调控, 昆明医科大学学报.
[13]	李婷, 边莉. microRNAs在肺癌中的相关研究及进展, 昆明医科大学学报.
[14]	李正金. 13种高危型HPV感染联合TCT检查在大理地区宫颈癌筛查中的应用, 昆明医科大学学报.
[15]	魏洁. Twist在中晚期宫颈癌组织中的表达及临床意义研究, 昆明医科大学学报.
[16]	李铮. 云南地区人乳头瘤病毒16型感染及与其他亚型混合感染状况分析, 昆明医科大学学报.
[17]	赵东岩. 2013年昆明市2 899例妇科宫颈糜烂患者人乳头瘤病毒检测分析, 昆明医科大学学报.
[18]	严志凌. 宿主p53基因多态性与HPV16 感染、宫颈癌发生发展的相关性, 昆明医科大学学报.
[19]	刘慧瑾. 宫颈癌组织Vimentin的表达与淋巴转移宫旁浸润的关系研究, 昆明医科大学学报.
[20]	黄雅. Brn-3a、PPAR-γ在宫颈癌及癌前病变中的表达, 昆明医科大学学报.